Assisted reproduction technologies have profoundly transformed the field of reproductive medicine, bringing hope to millions of people facing fertility problems worldwide.
A recent review conducted by Rumiana Tenchov and Qiongqiong Angela Zhou, from CAS, a division of the American Chemical Society in Columbus, Ohio (United States), comprehensively analyzes how these tools are evolving.
From the most established techniques to the most innovative experimental methods, science continues to push the boundaries of what is possible to improve the success rates and safety of treatments.
The different sections of this article have been assembled into the following table of contents.
Artificial intelligence (AI) is increasingly being integrated into fertility treatments to improve the accuracy and efficiency of clinical processes. This technology stands out for its ability to process large amounts of data and help specialists make more personalized decisions:
The progressive adoption of these technologies not only optimizes clinical outcomes but also contributes to reducing treatment times and costs associated with failed cycles, representing a fundamental advance for the accessibility of assisted reproduction treatments.
Another of the most revolutionary advances in this field is in vitro gametogenesis (IVG). This experimental procedure allows for the creation of eggs or sperm from somatic cells of the body, such as skin or blood cells.
To achieve this, the process involves the differentiation of pluripotent stem cells into gametes, mimicking the natural progression that occurs in the human body. Although it is still an experimental technique in humans, it has shown success in animal models.
This technology could offer unprecedented solutions in the near future for people who cannot produce their own gametes due to medical conditions or age, or for same-sex couples to have biological children.
However, its application in human clinics will require profound safety validation and will be subject to strict ethical and legal considerations.
Stem cell-based therapies and gene editing are positioned as key pillars in the future of human reproduction. Stem cells offer a regenerative potential that allows improving the reproductive conditions of the patient.
Although editing genes in human embryos for reproductive purposes remains prohibited or heavily regulated in many countries for ethical and safety reasons, this research represents a crucial step toward preventing genetic diseases before pregnancy occurs.
We make a great effort to provide you with the highest quality information.
🙏 Please share this article if you liked it. 💜💜 You help us continue!
Tenchov R, Zhou QA. Assisted Reproductive Technology: A Ray of Hope for Infertility. ACS Omega. 2025 May 23;10(22):22347-22365. doi: 10.1021/acsomega.5c01643. PMID: 40521551; PMCID: PMC12163768. (View)